In particular, we assessed the effect of BK channel agonists, on TRPML1 channel activity and the clearance of lysosomal storage in human fibroblasts from NPC1, mild cases of ML4, NPA and Fabry disease3, 4, 8. This evidence concerns the gene MCOLN1 and mucolipidosis type IV.